Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683839 · ClinicalTrials.gov registry record · Phase 2
Tobacco Cessation Via Public Health Dental Clinics
A Phase 2 study of Smoking, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,637
- Enrollment target
- 3
- Study locations
NCT00683839 is a Phase 2 study of Smoking that has completed, run by Oregon Research Institute. The registered enrollment target is 2,637 participants, above the 434-participant average among 123 other Smoking trials with a reported enrollment target (508% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT00683839, a Phase 2 study of Smoking, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,637 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study will examine the effectiveness of public health dental practitioners using a brief office based intervention designed to help patients quit smoking or smokeless tobacco use, as compared to usual care.
Conditions Studied
Interventions
- BEHAVIORAL Brief tobacco counseling
Study Locations (3)
Mississippi
- University of Mississippi - Jackson
New York
- Columbia University - New York
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,637 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683839
The ClinicalTrials.gov registry entry for NCT00683839 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,637 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 434-participant average among 123 other Smoking trials with a reported enrollment target (508% higher). The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Brief tobacco counseling is the first listed.
NCT00683839 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Mississippi, New York, Oregon.
Frequently Asked Questions
What is clinical trial NCT00683839 about?
NCT00683839 is a clinical study titled "Tobacco Cessation Via Public Health Dental Clinics". The study will examine the effectiveness of public health dental practitioners using a brief office based intervention designed to help patients quit smoking or smokeless tobacco use, as compared to usual care.
What is the current status of trial NCT00683839?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,637 participants. The study started on 2006-01. Estimated completion is 2009-09.
What conditions does trial NCT00683839 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT00683839?
The interventions under investigation include: Brief tobacco counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00683839?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00683839 being conducted?
This trial has 3 study locations across Mississippi, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
RECRUITING · Phase 2
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
RECRUITING · Phase 2
-
App for Reducing Cravings to Smoke
RECRUITING · Phase 2
-
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
ACTIVE NOT RECRUITING · Phase 2
-
Proactive Health Intervention for Tobacco Users (Get PHIT)
COMPLETED · Phase 2
-
Computer-Assisted Intervention for Smoking During Pregnancy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.